House Bill 96 or the Reproductive Health Bill and some suspicious provisions
- Global sales of contraceptives in 2008 were $9.9 billion and, with 2% growth, sales reached $10.1 billion in 2009. This market is expected to rise at a CAGR of 4.8% and reach $13.5 billion by 2015.
- The contraceptive market is led by hormonal contraceptives with more than a 78% share. This segment was worth $7.9 billion in 2009 and is expected to increase to $8.2 billion in 2010 and $9.4 billion by 2015, a compound annual growth rate of (CAGR) of 2.8%
- Barrier contraceptives have a smaller market share than hormonal contraceptives but are expected to grow at a higher rate. This segment was worth $2 billion in 2009 and is expected to be valued at $2.3 billion in 2010 and $3.5 billion in 2015, an 8.5% compound annual growth rate (CAGR).